These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 310703)
1. Hazards of sulphinpyrazone. Mattingly D; Bradley M; Selley PJ Br Med J; 1978 Dec 23-30; 2(6154):1786-7. PubMed ID: 310703 [No Abstract] [Full Text] [Related]
2. Potentially serious interaction of warfarin with sulphinpyrazone. Thompson PL; Serjeant C Med J Aust; 1981 Jan; 1(1):41. PubMed ID: 7207296 [No Abstract] [Full Text] [Related]
3. Hazards of sulphinpyrazone. Ahmad S Br Med J; 1979 Feb; 1(6159):344-5. PubMed ID: 421113 [No Abstract] [Full Text] [Related]
4. Possible interaction of sulfinpyrazone with coumarins. Davis JW; Johns LE N Engl J Med; 1978 Oct; 299(17):955. PubMed ID: 692605 [No Abstract] [Full Text] [Related]
5. Decrease in renal function due to sulphinpyrazone treatment early after myocardial infarction. Lijnen P; Boelaert J; van Eeghem P; Daneels R; Schurgers M; de Jaegere P; van der Stichele E; Vincke J; Fagard R; Verschueren LJ; Amery A Clin Nephrol; 1983 Mar; 19(3):143-6. PubMed ID: 6340878 [TBL] [Abstract][Full Text] [Related]
6. Sulphinpyrazone-induced acute renal failure. Durham DS; Ibels LS Br Med J (Clin Res Ed); 1981 Feb; 282(6264):609. PubMed ID: 6781590 [No Abstract] [Full Text] [Related]
7. Phenylbutazone and sulfinpyrazone interaction with oral anticoagulant phenprocoumon. O'Reilly RA Arch Intern Med; 1982 Sep; 142(9):1634-7. PubMed ID: 7114982 [TBL] [Abstract][Full Text] [Related]
8. Sulphinpyrazone after myocardial infarction. Kane SH Br Med J; 1978 Jun; 1(6125):1484. PubMed ID: 647347 [No Abstract] [Full Text] [Related]
9. Myocardial re-infarction and sulphinpyrazone. Watt M N Z Med J; 1978 Sep; 88(619):213. PubMed ID: 280805 [No Abstract] [Full Text] [Related]
10. Sulphinpyrazone in acute myocardial infarction. Lijnen P; Verschueren LJ; Amery A; Boelaert J; Daneels R; Schurgers M; Van Eeghem P Br Med J; 1980 Oct; 281(6246):1005. PubMed ID: 7427530 [No Abstract] [Full Text] [Related]
11. Renal dysfunction with sulphinpyrazone therapy. Boelaert J; Van Eeghem P; Fagard R; Lijnen P; Daneels R; Schurgers M; Verschueren LJ; Amery A Am Heart J; 1982 Jul; 104(1):174-5. PubMed ID: 7090980 [No Abstract] [Full Text] [Related]
12. Acute myelomonocytic leukaemia and multiple myeloma after sulphinpyrazone and colchicine treatment of gout. Witwer MW; Schmid FR; Tesar JT Br Med J; 1976 Jul; 2(6027):89. PubMed ID: 1064465 [No Abstract] [Full Text] [Related]
14. A study of the effect of sulphinpyrazone ('Anturan') on blood viscosity. Johnston RV; Lowe GD; Drummond MM; Forbes CD; Prentice CR Curr Med Res Opin; 1979; 6(4):271-3. PubMed ID: 527353 [TBL] [Abstract][Full Text] [Related]
18. [Intramural hematoma of the intestine caused by anticoagulants (3 cases, 1 of them of the colon)]. Huguier M; Vinh TS; Cerbonnet G Chirurgie; 1972 May; 98(7):427-32. PubMed ID: 4538778 [No Abstract] [Full Text] [Related]
19. Effects of sulphinpyrazone and aspirin on gastrointestinal blood loss in man. Dawson A; Lavinski C; Parsons V; Weston MJ Thromb Res; 1978 May; 12(5):947-50. PubMed ID: 307835 [No Abstract] [Full Text] [Related]
20. Clinical pharmacokinetics and potentially important drug interactions of sulphinpyrazone. Pedersen AK; Jakobsen P; Kampmann JP; Hansen JM Clin Pharmacokinet; 1982; 7(1):42-56. PubMed ID: 7042172 [No Abstract] [Full Text] [Related] [Next] [New Search]